
Children and adolescents who are reinfected with SARS-CoV-2 face a significantly higher risk of developing long COVID, according to a large, multi-institutional study published in The Lancet Infectious Diseases.

Patients with long COVID-19 in the U.S. report far higher rates of brain fog, depression and cognitive symptoms than patients in countries such as India and Nigeria, according to a large international study led by Northwestern Medicine.

A recent study has provided the first side-by-side comparison of how three major COVID-19 vaccine types differ in triggering immune responses and sustaining protection.

Scientists have identified dozens of human proteins that SARS-CoV-2, the virus that causes COVID-19, depends on to replicate and spread, according to a recent study published in the journal PLOS Biology.

Most children with life-threatening heart inflammation stemming from COVID-19 tend to recover within six months of infection, according to a multicenter study published in JAMA Pediatrics.

Vaccination status does not impact the severity of neurological symptoms of long COVID, according to a Northwestern Medicine-led study published in Brain Communications.

Patients with opioid use disorder enrolled in Medicaid were less likely to receive telehealth care after the COVID-19 pandemic compared to patients with private insurance, according to a recent Northwestern Medicine study.

A new Northwestern Medicine study has revealed a connection between COVID-19 infection and cancer regression, which could pave the way for novel cancer treatments.

The COVID-19 virus spreads via mucus once inside an infected airway, according to a Northwestern Medicine study published in Nature Communications.

Investigators led by Pablo Penaloza-MacMaster, PhD, associate professor of Microbiology-Immunology, have discovered that administering an antibody treatment four days after mRNA vaccination significantly improved vaccine efficacy in mice, according to findings published in The Journal of Clinical Investigation.